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Alzheimer's disease (AD), and other neurodegenerative diseases, results from an 
extracellular accumulation of beta-amyloid plaques, which are composed of misfolded 
peptide oligomers of beta-amyloid.  The accumulation is thought to be due to the failure 
of the glymphatic system, a waste clearance system in brain, which uses aquaporin-4 
(AQP4) protein water channels.  This protein exists as heterotetramers of M1 and M23 
isoforms from splice variants of AQP4.  Previous studies suggested that Herpes Simplex 
Virus-1 (HSV-1) infection of the central nervous system (CNS) may be correlated to AD 
development.  However, the effect of HSV-1 on the glymphatic system has not been 
definitively established.  The objective of this study was to investigate HSV-1 infection 
on AQP4 expression in human brain-derived glial cells.  Our preliminary results suggest 
that HSV-1 infection of the cells leads to lower protein levels of M23 isoform.  These 
results suggest that HSV-1 infection may potentially interfere with the function of the 
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Table of Abbreviations  
AD  Alzheimer’s disease 
Aβ                   β-amyloid peptides 
APP  β-amyloid precursor proteins 
AQP  Aquaporin 
AQP4  Aquaporin 4 
CNS  Central Nervous System 
CPE  Cytopathic Effect 
CSF  Cerebrospinal fluid 
DAPI  4',6-diamidino-2-phenylindole 
FBS  Fetal bovine serum  
HPI  Hours post-infection  
HRP  Horseradish peroxidase 
HSV-1  Herpes Simplex Virus Type 1 
HSV-2  Herpes Simplex Virus Type 2 
HSV1-tk Herpes Simplex Virus Type 1 thymidine kinase 
IFA  Immunofluorescence assay 
ISF   Interstitial fluid 
M1  M1 isoform tetramer 
M23  M23 isoform tetramer  
MEM  Minimum Essential Medium  
MOI  Multiplicity of infection  
OAP  Orthogonal arrays of particles 
PBS   Phosphate buffered saline 
PCR  Polymerase chain reaction 
PSV  Pseudorabies virus 
qPCR  Real-time PCR 
RT  Reverse transcription  
TLR2  Toll-like receptor 2 
TLR9  Toll-like receptor 9 
TNF  Tumor necrosis factor 
TPM  Two-photon microscopy 
WB  Western blotting 
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Chapter 1: Introduction 
Alzheimer’s disease (AD), a neurodegenerative disease, is characterized by low, 
irreversible deterioration of memory and cognitive function (Johanson et. al, 2008).  
While the cause of Alzheimer's disease is currently unknown, scientists have identified 
numerous physiological changes that occur during AD.  The most notable of these 
physiological changes is the decreased clearance and degradation of the β-amyloid 
peptides whose buildup could result in an increased risk of developing plaques associated 
with neurodegenerative diseases (Strittmatter et. al, 1993).  These β-amyloid peptide 
chains of 40-42 amino acids arise from the cleavage of β-amyloid precursor proteins 
(APP), which are transmembrane proteins expressed at high levels in the brain.  APP can 
be metabolized by the action of secretases (ɑ and γ) (Ehehalt et. al, 2003).  When APP is 
metabolized by the intramembranous γ-secretase complex, it results in the production of 
β-amyloid peptides, which are typically deposited into the extracellular space or degraded 
in lysosomes (Ehehalt et. al, 2003).  When the β-amyloids become internalized in a 
clathrin-coated endosomal compartment, they are folded into a β-pleated shape and form 
long aggregates called plaques (Ehehalt et. al, 2003).  The plaques are deposited into the 
extracellular space following vesicle recycling (Ehehalt et. al, 2003).  A study indicates 
that misfolded β-amyloid plaques can bind strongly to neurons and disrupt synapse 
connections that are important for neurotransmission and memory (Kim et al., 2013).  
Because of the deleterious health implications from the accumulation of β-amyloid 
plaques, it is important to understand the glymphatic system, which facilitates the 
removal of β-amyloid peptides to prevent the development of these plaques. 
7 
In healthy brains, the glymphatic system utilizes astrocytes in the central nervous 
system (CNS) to flush interstitial fluid
1
 (ISF) through perivascular space, thus eliminating 
natural waste and byproducts generated from normal CNS functions (Thrane et al., 2014).  
The end feet of the astrocytes contain the water channel protein aquaporin-4 (AQP4), 
which is responsible for facilitating bulk flow of ISF to clear the β-amyloid from the 
cerebrospinal fluid (CSF) (Thrane et al., 2014).  AQP4 is highly expressed in the brain 
and its main function is to remove β-amyloid peptides.  Results from AQP4-knockout 
mice
2
 experiments show that the deletion of AQP4 in the brain displays statistically 
significant reductions in clearance of β-amyloid peptides from the ISF (Iliff et al., 2012).  
Impaired function or decreased levels of AQP4 in the glymphatic system could lead to 
reduced clearance of β-amyloid peptides and therefore potentially contribute to the 
development of neurodegenerative diseases such as AD.  
A functional decrease of the glymphatic system can also be caused by an 
alteration in the AQP4 localization.  Researchers have studied the perivascular 
localization of AQP4 within postmortem frontal cortices and found that in individuals 
displaying signs of AD, the AQP4 localization was shifted from uniformly distributed 
throughout the cortical layers to varying amounts dependent on cortical layer depth 
(Zeppenfeld et al., 2017).  This change in AQP4 localization to deeper cortical layers is 
also correlated with increased β-amyloid plaque within the postmortem brains of the AD 
                                                 
1
 ISF is a water based solvent in the body that bathes tissues and transports metabolic waste, nutrients, 
signaling molecules, and immune response molecules.  It is found in between cells in what is known as 
tissue space (Wiig & Swartz, 2012).   
2
 In AQP4-knockout mice, the AQP4 gene in the mouse DNA is disrupted by genetic engineering to 
eliminate the expression of AQP4 protein, which allows researchers to examine the function of AQP4 and 
the effects of its deletion (Iliff et al., 2012).    
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patients, which suggests the changes in AQP4 localization may be a contributing factor 
for the presence of β-amyloid plaques in the aged brain (Zeppenfeld et al., 2017).  
AQP4 disruption affects the glymphatic system by decreasing its waste clearance 
function.  However, the impact from viral infections of neuroglial cells on AQP4 or the 
glymphatic system is not well understood.  The neuronal infection by Herpes Simplex 
Virus Type 1 (HSV-1) is suspected to be a risk factor for AD (Itzhaki et al., 1997;  
Itzhaki, 2014).  HSV-1, a neurotropic double-stranded DNA virus, is widespread in 
human populations.  This virus primarily infects humans through the oral mucosa, 
undergoing lytic replication (Lewandowski, Zimmerman, Denk, Porter, & Prince, 2002).  
In chronic infections, the newly produced HSV-1 particles can then enter sensory 
neurons, as well as microglia and astrocytes, and establish latency, with no visible 
symptoms or viral replication (Li et. al., 2011; Marques et al., 2006).  Certain conditions, 
such as a weakened immune system from aging, stress, or immunosuppression, can result 
in reactivation of HSV-1 virus.  One proposed mechanism is that HSV-1-induced 
inflammatory response might lead to disruption of the AQP4 in astrocytes. 
The objective of our research was to study the effect of HSV-1 infection on AQP4 
expression.  In this study, we infected human brain-derived astrocytes with HSV-1 and  
our results suggest that HSV-1 infection might induce reduction of AQP4 protein level.  
We hypothesize that this downregulation is a result of decreasing AQP4 gene expression 
or increasing AQP4 protein degradation.  There is no conclusive data about the 
relationship between HSV-1 infection and AQP4 RNA level.  Further research is needed 
to examine the HSV-1 effect on AQP4 expression.  Examining the effects of HSV-1 
infection on AQP4 will provide insights on the potential effect of HSV-1 infection on the 
9 
glymphatic system, because an alteration in AQP4 could impact the removal of β-
amyloid peptides and contribute to the development of AD.  
Chapter 2: Literature Review 
2.1 The Glymphatic System  
2.1.1 Overview of the System 
Like the complex network of the lymphatic system which removes metabolic 
waste products from the body, the recently discovered glymphatic system removes waste 
from the intercellular space within the brain.  The glymphatic system uses perivascular 
channels, formed by astroglial cells around blood vessels, to cause bulk flow of CSF, 
which contains proteins and metabolites, out of the brain, as illustrated in Figure 1 
(Johanson et al., 2008).  The glial cells, specifically astrocytes, use projections known as 
end feet to form a network around the exterior of arteries and veins inside the brain – 
composing the blood brain barrier (Iliff et al., 2012).  The end feet of the AQP4 help 
facilitate the bulk flow of CSF as it flows throughout the brain.  The CSF is pumped 
through the brain along the channels surrounding arteries, where it is then collected and 
drained from the brain (Iliff et al., 2012).  Astrocytes, a specific type of glial cells, play a 
crucial role in forming the structure of the glymphatic system.  Astrocytic processes 
encompass 97% of all the vasculature in the CNS and form small channels that allow 
CSF to flow into the brain and around the blood vessels (Verkhratsky, Nedergaard, & 
Hertz, 2015).  An improperly functioning glymphatic system could lead to negative 
outcomes including neurodegenerative diseases such as AD, Parkinson’s, and 
Huntington’s (Johanson et al., 2008).  
10 
 
Figure 1. Diagram of the glymphatic system in the brain (Iliff et al., 2012). 
 
When researchers studied the glymphatic system through two-photon microscopy 
(TPM) to locate fluorescent tracers in the brains of live mice, they found that 
hyperphosphorylated proteins, τ- and β-amyloid peptides, produced neurotoxic conditions 
that lead to AD (Nedergaard, 2013).  These peptides are cleared by the flow of CSF and 
ISF through the glymphatic system.  The aquaporin control the flow of the fluids which 
will determine the amount peptides removed.  The peptides accumulate in the brain 
naturally, but the buildup of the peptides is what can lead to neurodegenerative diseases 
as they block synapse connections and interfere with memory (Palop & Mucke, 2010).  
The CSF and ISF flush the brain to rid it of these peptides.  However, the glymphatic 
system of mice with AQP4 mislocated to astrocytic cell bodies does not clear as much 
soluble protein as mice with normal AQP4 water channels (Nedergaard, 2013).  As a 
result, the β-amyloid-induced synaptic depression contributes to synaptic N-methyl-D-
11 
aspartate (NMDA) receptor desensitization.
3
  Any damage to this receptor can lead to 
weakened neurons and loss of normal memory function, which are physiological 
symptoms of AD and other neurodegenerative diseases (Palop & Mucke, 2010).   
2.1.2 Aquaporin-4 
Aquaporin (AQP) is a type of  transmembrane protein that forms water channels 
for cells throughout the human body (Verkman, Phuan, Asavapanumas, & Tradtrantip, 
2013).  Many aquaporins have been found in glial cells such as AQP1, AQP3, AQP4, 
AQP5, AQP8, and AQP9 (Jung et al., 1994).  AQP4 is found in the eyes, ears, skeletal 
muscle, kidney collecting muscle, and the membranes of the end feet of astrocytes in the 
CNS (Neely, 2001).  The main function of AQP4 in the brain is to maintain water 
balance, neuroexcitation, and glial cell migration (Crane, Tajima, & Verkman, 2010).   
Aquaporins that are comprised of six transmembrane alpha-helices form tetramers 
in pores allowing for water or other small molecules to pass through (Verkman, Phuan, 
Asavapanumas, & Tradtrantip, 2013).  As water channel membrane proteins, aquaporins 
ensure water homeostasis, serve as transporters for osmosis, and in some cases, transport 
small polar solutes such as glycerol.  AQP4 in astrocytic cell membrane is comprised of 
the same structure as other aquaporins.  This protein plays a key role in the glymphatic 
system and the flow of CSF throughout the brain to remove β-amyloid peptides.  Due to 
the important role of AQP4 in the glymphatic system, we were interested in the effect of 
HSV-1 infection on AQP4. 
                                                 
3
 NMDA is a glutamate receptor which facilitates calcium influx under depolarized conditions in the 
postsynaptic membrane.  This channel is critical for the development of the CNS, neuroplasticity and 
memory processes (Blanke & VanDongen, 2009).   
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2.1.3 M1 and M23 Isoform Tetramers 
 AQP4 is composed of two isoforms, M1 and M23
4
.  Of the two types, M1 is the 
full-length isoform of the protein that initiates translation at Met-1, while M23 is the 
shorter isoform starting at Met-23, due to alternative splicing (Jin et al., 2011; Tajima, 
Crane, & Verkman, 2010).  The AQP4 assembles into an orthogonal array of particles 
(OAP), which are critical in the function of AQP4 as the size of the structural aggregates 
determines the rate of water movement (Silberstein et al., 2004).  The size of this 
formation is determined by the ratio of M23:M1 tetramers.  A greater ratio of M23:M1 
tetramers produce larger OAPs (Crane, Tajima, & Verkman, 2010).  A lower ratio of 
M23:M1 produces a smaller OAP as illustrated in Figure 2 (Jin et al., 2011).  Ratios with 
more M23 isoforms create OAPs of greater than 100 particles while ratios with fewer 
M23 isoforms form small arrays of fewer than 12 particles (Crane, Tajima, & Verkman, 
2010).   
The OAP assembly size determines diffusion (Tajima, Crane, & Verkman, 2010).  
Previous studies have shown that changing the M23:M1 ratio has an effect on the OAP 
size and thus AQP4 function, as depicted in Figure 2 (B) (Jin, Rossi, & Verkman, 2011).  
Increasing the ratio greatly increases OAP size, while varying the ratio allowed for 
marked heterogeneity in OAP size (Jin, Rossi, & Verkman, 2011).  Our research focused 
on the M23 isoform instead of the M1 isoform, because M23 amount determines the 
assembly size of OAPs (Tajima, Crane, & Verkman, 2010).  
                                                 
4
 New names are proposed for the M1 isoform as AQP4a and M23 tetramer as AQP4c.  However, to 
establish consistency in the following discussion, the conventional terminology of M1 and M23 was 
maintained in this thesis (Potokar, Jorgačevski, & Zorec, 2016).  
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Figure 2. OAP assembly from AQP4 heterotetramers M1 and M23 isoforms.  (a) Shows 
potential sites of the M23-M23 interactions as well as the possible AQP4 M1/M23 
heterotetramers.  (b) Changing the M23:M1 ratio affects the size of OAPs (Jin, Rossi, & 
Verkman, 2011).  
2.2 Herpes Simplex Virus 1  
2.2.1 Classification 
 There are three subfamilies in the family of Herpesviridae: Alphaherpesvirinae, 
Betaherpesvirinae, and Gammaherpesvirinae (Whitley, 1996).  HSV-1 belongs to the 
Alphaherpesvirinae subfamily.  Additional viruses in the Alphaherpesvirinae subfamily 
include varicella zoster virus (VZV), Herpes Simplex Virus 2 (HSV-2), and Pseudorabies 
Virus (PSV) (McGeoch & Cook, 1994).  HSV-1 belongs to the genus Simplexvirus.  The 
members of genus Simplexvirus have specific characteristics such as a short replicative 
cycle, a broad host range and latent infection in neurons (Whitley, 1996; International 
Committee on Taxonomy of Viruses, 9th Report, 2011).  HSV-1 is a virus that only 
infects humans (McGeoch & Cook, 1994).   
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2.2.2 HSV-1 Structure  
 HSV-1 is an enveloped virus containing double stranded DNA (Grünewald et al., 
2003).  The overall structure of HSV-1 virions consists of three main components: the 
nucleocapsid, the tegument, and the lipid envelope, as depicted in Figure 3 (Grünewald et 
al., 2003).   
 
Figure 3. Surface representation for a three-fold view of HSV-1.  (a) Shows the outer 
layer of the virus as well as the core.  (b) The virus has both a 5- and 6-fold axis 
representing the density distribution (Schrag, Prasad, Rixon, & Chiu, 1989). 
 
The HSV-1 nucleocapsid contains the genome of the virus and is icosahedral in 
structure.  The virion is surrounded by the viral envelope that consists of a lipid bilayer 
and eleven documented glycoproteins that function in HSV-1 binding and interacting 
with host cells (Kelly, Fraefel, Cunningham, & Diefenbach, 2009).  In between the viral 
envelope and the nucleocapsid is the tegument, which aids processes involved in viral 
replication (Kelly, Fraefel, Cunningham, & Diefenbach, 2009).    
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2.2.3 HSV-1 Replication 
HSV-1 is transmitted orally between humans.  The virus first infects the oral 
mucosa, a protective lining found in the mouth surrounding the oral cavity and the 
esophagus (Vorvick, 2014; Squier & Kremer, 2001).   
To initiate infection, HSV-1 glycoproteins on the viral envelope bind to the host 
cell surface receptors (Turner, Bruun, Minson, & Browne, 1998).  The viral envelope 
then fuses with the host cell membrane and allows the nucleocapsid to enter the 
cytoplasm with the help of multiple proteins from the tegument region.  The nucleocapsid 
moves to the perinuclear area and releases the viral genome into the nucleus.  HSV-1 
replication occurs in a specific order in gene expression: immediate-early genes, early 
genes, and late genes (Whitley, 1996).  The immediate-early genes encode regulatory 
proteins.  The early genes encode enzymes for replicating viral DNA.  The late genes 
encode structural proteins for virion packaging and assembly (Whitley, 1996).  Virions 
are then released from the cell through exocytosis.  This is the lytic cycle of HSV-1 and 
the process is shown in Figure 4, which depicts the HSV-1 life cycle in three stages.    
After infecting the oral mucosa, HSV-1 can enter sensory nerve endings and 
infect the sensory neurons, where it enters latent infection with no visible symptoms or 
viral replication (Knipe et al., 2007).  However, HSV-1 can be reactivated and cause the 
characteristic recurrent cold sores (Vorvick, 2014).   
Studies have indicated that HSV-1 can hijack exosomal pathways to ensure its 
survival and persistence (Gallo, et al., 2017).  The virus could use the extracellular 
vesicles as mediators for intercellular communication and microenvironment 
16 
modifications.  Hence, HSV-1 causes a persistent
5
 infection that remains in the host for 
life. 
 
Figure 4. Illustration of the HSV-1 life cycle in three stages.  The cycle begins with the 
attachment and entry of the virus, and ends with the exocytosis of newly replicated 
viruses (Murray, Rosenthal, & Pfaller, 2005). 
2.2.4 Epidemiology 
In the U.S., an estimated 51% of the population over the age of 12 tested positive 
for HSV-1 and approximately 90% of adults have been exposed to the virus, most of 
whom are infected by age 20 (Xu et al., 2002; Vorvick, 2014).  Approximately 16% of 
                                                 
5
 Persistent viral infections occur when certain viruses enter a host and are never fully removed from the 
host body.  Persistent viruses can exist in the host body as a latent, chronic, or slow infection (Boldogh, 
Albrecht, & Porter, 1996).   
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the population tested positive for both HSV-1 and HSV-2 (Xu et al., 2002).  Among the 
people who tested positive for HSV-2, 76% were also tested positive for HSV-1 (Xu et 
al., 2002).    
HSV-1 infection is incurable because if a person is infected, he or she will carry 
the virus for life, though some may not experience any symptoms (WHO, 2017).  HSV-1 
infection can lead to either mild or acute symptoms, which are well recognized as blisters 
or rashes around the mouth (Vorvick, 2014).  
HSV-1 is spread through both direct contact from an infected person’s saliva from 
activities such as kissing, and indirect contact from sharing items that come in contact 
with the infected saliva (CDC, 2014).  HSV-1 is transmitted from neuronal axons to 
epidermal cells, where they then spread into the mucosal membranes for transmission to a 
new host (Mikloska & Cunningham, 2001).  Another mode of transmission could be by 
indirect or direct contact with open herpes sore (Vorvick, 2014). 
2.2.5 Pathogenesis  
When HSV-1 enters the neuron, the viral replication can enter a latent phase 
where the virus remains present but is inactive.  When microglial cells
6
 detect the 
presence of HSV-1 through the pattern recognition receptors TLR2 or TLR9, these cells 
release small signaling proteins called cytokines, such as interferons and tumor necrosis 
factors (TNF).  They trigger a response to control HSV-1 replication and inhibit the 
reactivation of HSV-1 (Sørensen et al., 2008).   
                                                 
6
 Microglial cells are located in the central nervous system (CNS) that comprise around 20% of all glial 
cells, with microglia maintaining brain homeostasis and acting as an immune defense for the brain 
(Kreutzberg, 1995).   
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At a later time, spontaneously or based on certain factors
7
, the virus can exit the 
latency phase, reactivate, and attack the host body again.  Though a healthy immune 
system may be able to inhibit HSV-1 and keep the virus in its latency phase, when the 
system is compromised and HSV-1 is allowed to reactivate, the virus can enter the CNS 
in some rare cases and cause Herpesviral encephalitis
8
 (Conrady, Drevets, & Carr, 2009).  
Of these cases, there is a reported 70% mortality rate in untreated patients and 30% 
mortality rate in treated patients (Yao et al., 2014).  Thus, while the symptoms of HSV-1 
may seem harmless, they can result in major health implications.  HSV-1 is not just 
limited to neurons; these viruses also infect other cell types including astrocytes (Li et al., 
2011).   
It is theorized that infected glial cells allow for HSV-1 to efficiently replicate and 
spread over the CNS.  Astrocytes, in particular, are highly susceptible to HSV-1 
infections (Li et. al., 2011; Marques et al., 2006).  In a mouse model, it is reported that 
during the acute phase of HSV-1 encephalitis, there is a 35% downregulation in AQP4 
mRNA level at 7 days post infection, and 2.9-fold upregulation at 6 month post infection 
(Torres et al., 2007).  
Previous studies suggest that chronic HSV-1 infection may be a risk factor for the 
development of neurodegenerative diseases later in life, though there is no significant 
experimental evidence of HSV-1’s role as a pathogenic co-factor in AD (Beffert, 
Bertrand, Champagne, Gauthier, & Poirier, 1998).  HSV-1 is normally latent in aged 
                                                 
7
 Factors include fear, emotional stress, exposure to ultraviolet light, immunosuppression, chemotherapy, 
and many other factors (Scott, Coulter, Biagioni, O’Neill, & Lamey, 1997). 
8
 Herpesviral encephalitis is a viral infection of the CNS that results in encephalitis, which is an 
inflammation of the brain that has severe consequences on the infected patients such as seizures, headaches, 
change in behavior, and even brain damage and death (National Institute of Neurological Disorders and 
Stroke [NINDS], 2015).  
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brains but can potentially be reactivated during stress and immunosuppression, causing 
damage in the brain (Itzhaki et al., 1997; Wozniak et al., 2005).  Reactivated HSV-1 can 
cause direct and inflammatory damage, probably due to the accumulation of β-amyloid 
(Aβ) and of AD-like tau (P-tau) (Itzhaki et al., 1997; Wozniak et al., 2005).  Additionally, 
HSV-1 DNA has been found to be localized in amyloid plaques in AD (Wozniak et al., 
2009).  There are other harmful effects of infection including HSV-1 interaction with 
APP, resulting in HSV-1 and APP being transported together in the cell (Cheng et al., 
2011).  Furthermore, reactivation of the virus in brains could occur because of the 
response of toll-like receptors (TLRs) in HSV-1 infected astrocytes (Martin et al., 2014).  
This HSV-1 reactivation is correlated with neuroinflammation and neurodegenerative 
markers (phospho-tau and TauC3) (Martin et al., 2014).  Despite the studies that implicate 
HSV-1 infection in neurodegeneration to the subsequent development of AD, a definitive 
link between HSV-1 infection and AD is not established.  It is therefore necessary to 
investigate the impact of HSV-1 infection on astrocytes of the glymphatic system, which 
is implicated in the onset of neurodegenerative diseases.    
Chapter 3: Methodology  
 The major objective of this study was to assess the impact of HSV-1 infection on 
the function and the production level of AQP4 with specific interest in the M23 isoform.  
This study was not meant to research the enzymatic processes of the glymphatic system.  
The effect of HSV-1 on AQP4 was studied to contribute to a broader understanding of 
the glymphatic system.  The relationship between HSV-1 infection and AQP4 
downregulation was tested through the assessment of AQP4 protein levels in infected 
20 
cells by Western blot (WB) analysis, visualization of AQP4 localization using 
immunofluorescence assay (IFA), and the quantification of AQP4 RNA level through 
reverse transcription and real time polymerase chain reaction (RT-qPCR).   
3.1 Cell Culture, HSV-1 Infection, Virus Titration 
 The human fetal glial cell line, SVG, was a gift from Dr. Eugene Major of NIH 
(Major & Yacante, 1989).  SVG cells were used, rather than neuroglial cells from aged 
brains as the former may have fewer possible confounding variables that are often found 
in the latter.  The cell confluency remains high, between 80-90%, before infection.  This 
cell line was maintained with Minimum Essential Medium (MEM) supplemented with 
10% fetal bovine serum (FBS).  The cells were incubated at 37ºC with 5% CO2.  The 
cells in a T-25 flask were designated for maintenance and growth whereas cells in a 10 
cm diameter Petri dish were designated for storage in liquid nitrogen.  
 When passaging, the cells were washed three times with 1000 mL of phosphate 
buffered saline (PBS) to remove dead cells and FBS, then detached from the culture flask 
with 500 mL of trypsin.  The cells were then incubated for two minutes to allow time for 
the trypsin enzyme to detach the cells from the culture flask.  A portion of the detached 
cells were then plated into wells of culture plates and incubated for next-day infection, if 
the cells reached 90% confluency.  In order to infect the SVG cells, the HSV-1-GFP virus 
stock was diluted to reach the desired multiplicity of infection (MOI) (Lin, Yang, & 
Zhang, 2018; Ma, Yang, & Zhang, 2018).  HSV-1-GFP virus was a gift from Dr. 
Prashant Desai of Johns Hopkins University (Desai and Person, 1998).  The MOI levels 
varied in the experiments; however, we commonly used the MOIs of 0.1, 0.5, 1.0, and 5.0 
in this study.  Infected cells were harvested at varying time-points as stated in results or 
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figure legends.  Longer incubation time was needed to assess protein level change of 
AQP4 with WB.  Therefore, infected cells for WB were harvested between 9 hours post 
infection (hpi) and 48 hpi in this study.   
3.2 Quantification of AQP4 RNA Expression  
At the specified hpi, the cells were harvested using TRIzol Reagent (Thermo 
Fisher Scientific).  Total RNA was isolated from the cell lysate according to the 
manufacturer’s instructions and established methodologies (Lin, Yang, & Zhang, 2018; 
Ma, Yang, & Zhang, 2018).  Once isolated, the RNA was used in reverse transcription 
(RT) with a combination of oligo(dT) primers and random hexamers to synthesize cDNA 
and ensure all targets of interest were equally represented in the subsequent analysis.  The 
cDNA was subjected to a real-time PCR (qPCR) analysis as previously described (Yang 
et al., 2016).  The primers in qPCR are ICP0-F1 (5’-CATGCACCGCTTCTGCATCC-3’) 
and ICP0-R1 (5’-CGTCACGCCCACTATCAGGT-3’) for the detection of HSV-1; RR-
AQP4-F1 (5’- TCACCATGGTTCATGGAAAT-3’) and RR-AQP4-R1 (5’- 
CAGTCCGTTTGGAATCACAG-3’) were used for the detection of AQP4.  Transcripts 
of hRPL32, a housekeeping gene, were also detected for control as described (Yang et al., 
2016).  HSV-1 ICP0 plasmid (a gift from Dr. Qiyi Tang at Howard University) was used 
in the qPCR to obtain an HSV-1 standard curve to assess absolute ICP0 RNA copies.  As 
there should not be an HSV-1 related decrease in the transcript level of  hRPL-32, AQP4 
RNA level was assessed and shown as relative level after normalization with hRPL-32. 
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3.3 Western Blotting 
Total proteins in cell lysate samples were separated by SDS-PAGE and analyzed 
by Western blotting to identify AQP4, as described previously (Yang et al., 2016).  The 
Western blotting was done in three steps: first, separating the proteins by size; second, 
transferring the protein from the gel to a nitrocellulose membrane; and third, detecting the 
target protein using a corresponding primary antibody followed by a secondary antibody 
conjugated with horseradish peroxidase (HRP) (Yang et al., 2016).  The primary 
antibodies used in this study were against AQP4 (B-5) (Santa Cruz Biotechnology, Inc., 
Dallas, TX) and beta-tubulin (Sigma).  Mouse anti-HSV-1 gD monoclonal antibody 
(DL6) conjugated with HRP (Santa Cruz) was used for the detection of HSV-1 gD in a 
1:1000 dilution.  The chemiluminescence substrate was used to reveal the presence of 
HRP-conjugated antibody on the membrane.  The chemiluminescence signal acquisition 
and densitometry analysis were conducted using the Quantity One program (v4.6) and a 
Chemi-Doc XRS imaging system (Bio-Rad Laboratories, Hercules, CA).  The WB 
analysis provided us with relative protein levels in comparison to controls, though not an 
absolute measurement of the amount of target protein present in each sample (Yang et al., 
2016).   
3.4 Immunofluorescence Assay (IFA) 
IFA was conducted as previously described (Lin, Yang, & Zhang, 2018; Ma, 
Yang, & Zhang, 2018).  SVG cells were grown on cover glass slips in a 12-well culture 
plate.  The cells were fixed with 1% paraformaldehyde for 15 minutes at room 
temperature.  The AQP4 antibody was diluted at 1:50 ratio and applied onto the cover 
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glass, followed by incubation at 37ºC for 30 minutes.  Diluted goat anti-mouse IgG-
fluorescein isothiocyanate (FITC) conjugate (Sigma, St. Louis, MO) was then added to 
the cover glass followed by incubation at 37ºC for 30 minutes.  The 4',6-diamidino-2-
phenylindole (DAPI) was used to stain the DNA in the nucleus of the cells.  The cover 
glass was mounted onto slides using SlowFade Gold antifade reagent (Thermo Fisher) 
and observed under fluorescence microscopy.  The ZEISS Axiovert200M inverted 
fluorescence microscope and Axio Vision program were then used to image, process, and 
analyze the IFA slides. 
IFA was used to assess AQP4 expression and its location in the presence and 
absence of HSV-1 infection.  This technique was applied to ensure that the changes in 
AQP4 expression or location were indeed due to HSV-1 infection.   
Chapter 4: Results 
4.1 Optimization of HSV-1 Inoculation Amount and Infection Time  
Prior to analyzing the effects of HSV-1 infection on AQP4, the optimal infection 
time and MOI of HSV-1-GFP were determined by the observation of green fluorescence 
from HSV-1-GFP and cytopathic effect (CPE).  The time point/MOI combinations with 
high virus infection rate and low CPE were selected for additional experiments.  The titer 
of the HSV-1-GFP stock was determined by limiting dilution and titration in Vero cells 
for TCID50 (Yang et al., 2016).  SVG cells were initially infected with HSV-1-GFP at 
the MOI of 1.0 and 5.0.  The cells were imaged under fluorescence microscopy at 24 and 
48 hpi.  Compared to the mock-infected cells, the HSV-1-GFP infected cells displayed 
lower cell density as shown in the phase contrast image (Figures 5a & 5c).  At 24 hpi, 
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cells inoculated with an MOI of 5.0 displayed a higher number of positive fluorescence 
cells than those with an MOI of 1.0 (Figure 5a).  At 48 hpi, the difference in positive 
fluorescence between different MOI levels is less noticeable.  However, higher cell death 
is observed in the 48 hpi sample infected with 5.0 MOI rather than 1.0 MOI.  Compared 
to cells harvested at 24 hpi (Figure 5a), the 48 hpi cells (Figure 5c) had a higher rate of 
fluorescence-positive cells in both 1.0 MOI and 5.0 MOI-wells.  Based on the CPE at 24 
and 48 hpi (Figures 5a and 5c), 1.0 MOI inoculum was commonly used for SVG cell 
infection in our experiments.  In addition, infected cells at 48 hpi (Figure 5c) 
demonstrated a reduction in cell morphology quality and density.  Both infected wells 
displayed increased number of dead cells than that of their 24 hpi counterpart.  Therefore, 
cells were harvested before 48 hpi in the following tests.   
SVG cells were infected at an MOI of  0.1, 0.5, and 1.0 to further optimize the 
inoculum using WB analysis.  The cells were harvested at 24 and 48 hpi and mock-
infected cells were included for comparison.  WB results showed an increase in HSV-1-
GFP gD level with an increase in MOI, while the tubulin protein level remained 
unchanged (Figure 5b).  The same trend was observed for 48 hpi samples, except the 
protein level for 1.0 MOI appears equivalent to 0.5 MOI (Figure 5d).  Additionally, HSV-
1 GFP gD level is higher at 48 hpi than 24 hpi as shown in Figure 5. 
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Figure 5. HSV-1-GFP infection rate increases with time and MOI.  (a) Fluorescence microscopy at 24 hpi 
displays the presence of HSV-1-GFP infection shown in green fluorescence at 200x magnification.  (b)  
Increase in HSV-1 gD level along with incremental MOI-detected by Western blot analysis of 24 hpi 
samples at 200x magnification.  (c) Fluorescence and phase contrast microscopy at 48 hpi indicate higher 
rate HSV-1-GFP infection, lower cell confluency, and more dead SVG cells than at 24 hpi.  Increased 
number of dead cells present in infected wells at 48 hpi while few dead cells observed in mock-infected 
wells.  (d) Western Blot analysis demonstrates increase in HSV-1-GFP gD protein level along with MOI at 
48 hours.   
4.2 HSV-1 Induces Reduction of AQP4 Protein  
To analyze the effect of HSV-1 on AQP4 protein level, we infected SVG cells 
with HSV-1-GFP at the MOIs of 1.0, 5.0, and 10.  Figures 6a and 6b display our 
preliminary results that suggest AQP4 protein level decreased along with MOI increase 
and extended infection time.  In Figure 6a, AQP4 appears to be present as two bands, 
corresponding to 30/32 kDa.  The top band is assumed to be the M1 isoform (32 kDa) 
and the bottom band is the M23 isoform (30 kDa) (Rossi et al., 2009).  Compared with 
mock-infected cells, the M1 isoform band in the infected cells showed minimal change, 
while the M23 isoform band decreased.  This decrease in protein level is more apparent 
between mock-infected and 1.0 MOI infected cells.  M23 band strength appears roughly 
similar across the infection levels.  Yet, the tubulin level unexpectedly reduced in the 
cells with 5.0 and 10 MOI.     
26 
In Figure 6b, the temporal kinetics of AQP4 in HSV-infected cells were 
examined.  Compared to the mock-infected cells, HSV-infected cells appeared to have 
lower AQP4 levels at 24, 36, and 48 hpi.  In cells infected with the MOI of 5.0, AQP4 
level was lower than the cells with an MOI of 1.0.  The mock-infected cells had no 
observable change in AQP4 between 24 hpi and 48 hpi.  Tubulin band strength is roughly 
constant at each time point and MOI, however, a slight decrease is observed at 5.0 MOI 
in the 24 hpi sample.  This dip in band intensity can be attributed to a loading error when 
conducting the experiment.  Further study is needed to confirm the AQP4 protein level 
change in HSV-infected cells.  
 
Figure 6. AQP4 protein levels decrease relative to tubulin, a  housekeeping protein, in infected SVG 
samples.  (a) Western blot analysis shows that AQP4 decreases in HSV-infected cells.  (b) Western blot 
analysis examines AQP4 protein level in infected SVG samples from 24 to 48 hpi.   
4.3 AQP4 RNA Level in HSV-infected Cells is Inconclusive  
We attempted to determine the AQP4 transcript level in HSV-infected cells.  The 
SVG cells were infected with different MOI and harvested at different hpi.  Infected cells 
designated for RT-qPCR tests were harvested at shorter time points between 2 and 9 hpi.  
The time points were shortened to check the early levels of AQP4 after infection.   
Results from multiple experiments were not consistent due to various reasons, 
including technical errors in RNA isolation, RT, and qPCR that are described in further 
detail in the discussion.  The high discrepancies in qPCR results made the experiment 
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inconclusive and further work is needed to elucidate the effects of  HSV-1-GFP infection 
on AQP4 transcript level.   
4.4 Probable Altered Pattern of AQP4 in HSV-infected Cells 
 Immunofluorescence assay was used to determine whether AQP4 localization 
experienced a shift in HSV-infected cells in comparison to mock-infected cells.  The IFA 
images suggest that in mock-infected cells, AQP4 seemed to be evenly distributed 
throughout the cells (Figures 7a and 7b).  In HSV-infected cells, the AQP4 seemed to 
have a different distribution pattern from the mock-infected cells (Figure 7).  As a wide-
field fluorescence microscope was used to observe the IFA slide and take photos, the 
exact distribution pattern was difficult to conclude.  Repeated tests and confocal 
microscopy are needed to further examine the AQP4 subcellular location.  In addition, 
the images were adjusted separately to show the subcellular location pattern shift, which 





Figure 7. Immunofluorescence assay displays the location of AQP4 in HSV-infected SVG cells.  (a) IFA 
images of 24 hpi sample. DAPI (blue) AQP4 (red), and HSV-1-GFP (green) are shown.  (b) Location of 
AQP4 protein at 48 hpi for Mock, 1.0 MOI and 3.0 MOI.  
Chapter 5: Discussion 
A functioning glymphatic system is crucial for the removal of β-amyloid peptides 
and waste from the brain.  AQP4 is involved in ISF and CSF exchanges in the glymphatic 
system in the brain.  In this study, we have obtained preliminary data that suggests HSV-
1 induces AQP4 downregulation.  Optimization of HSV-1 virus inoculum and infection 
time indicates that SVG cells inoculated at an MOI of  0.1 and 1.0 and harvested between 
24 and 48 hpi were best for the study as shown in Figure 5.     
The preliminary results of this study indicate HSV-1 infection of SVG cells might 
lead to downregulation of AQP4.  Figure 6b showed that AQP4 was reduced in HSV-
infected cells, whereas tubulin protein had minimum change.  This suggests that 
downregulation of AQP4 by HSV-1 is not due to its universal downregulation of all 
cellular proteins.  Whereas M1 isoform level stayed relatively consistent, the M23 
isoform level decreased in the infected cells.  Despite not seeing a dose-dependent 
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decrease in AQP4, Figure 6a indicates the M23 isoform experiences a decrease in the 
presence of infection.  Because M23 isoform plays a major role in AQP4 tetramer 
formation, an alteration in the ratio between M23 and M1 following HSV-1 infection 
could impact the rate of waste removal in the glial cells.  However, further studies must 
be conducted to confirm our observations in the virus-infected cells.   
In a previous study of HSV-1 induced encephalitis in mice, there is a mild 
reduction of AQP4 RNA transcript in the acute phase of infection and an up-regulation in 
the long term (Torres et al., 2007).  However, our data regarding AQP4 RNA level is 
inconclusive as we lack replicability in our results.  Though multiple trials were 
conducted to assess the impact of HSV-1 infection on AQP4 transcripts, errors such as 
weak amplification curves indicating poor RNA quality and evidence of cross-
contamination between samples rendered the results unreliable.  Though inconclusive, 
our initial result suggests HSV-1 infection does not influence AQP4 transcript level.  If 
this observation were confirmed, lower AQP4 protein levels in HSV-infected cells could 
be attributed to changes at the protein level rather than the RNA level.    
Our IFA results suggest that the AQP4 pattern in HSV-infected cells was 
probably altered, which could potentially affect AQP4 function as well.  Zeppenfeld et al. 
(2017) concluded that AQP4 localization shifts towards deep cortical layers in AD 
patients.  It is possible that HSV-1 infection might induce AQP4 subcellular location 
change, however, further studies must be conducted to confirm the observation.  Our use 
of widefield microscopy instead of confocal microscopy could account for the less clear 
IFA images. 
30 
Despite our effort and the volume of data we have gathered, the experiments must 
be repeated to confirm our observations.  A majority of our results reflect qualitative data 
that could not be quantified or statistically analyzed.  Quantification of protein bands in 
WB analysis through the QuantityOne program produced inconclusive results due to the 
weakness of the bands.  Additionally, results obtained through RT-qPCR were omitted 
from this study due to lack of replicability and variation between samples due to human 
error (e.g. HSV-1 transcripts detected in mock samples).  As a result, statistical analysis 
and error bars did not reflect accurate trends in data obtained.  
Some other possible sources in error for our research include cell contamination 
and discrepancies in techniques between group members.  In regards to cell 
contamination, the SVG cells experienced a recurring fungal infection due to unknown 
reasons.  Proper personal protective equipment was required at all times and proper 
sterilization techniques were followed.  However, based on the high rate of 
contamination, it became evident that the team’s efforts to follow the aseptic techniques 
required in handling cells were not sufficient.  To mediate this issue, in the late stage of 
the study, the team relied on a graduate student, Liping Yang to maintain SVG cells on 
our behalf.  All of our procedures and data are stored in a shared Google Drive folder for 
any team member to reference to alleviate variation in technique.  These were often 
cross-checked with our principal investigator and the graduate students in the lab to 
ensure accuracy.   
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Chapter 6: Conclusion 
Our research investigated the impact of HSV-1 infection on AQP4, a protein 
critical to the proper functioning of the glymphatic system.  Decreased clearance of β-
amyloid peptides by a malfunctioning glymphatic system can lead to an increased risk of 
developing neurodegenerative diseases such as AD (Strittmatter et. al, 1993).    
We studied the effects of HSV-1 infection on AQP4 by infecting cells at varying 
MOI.  Western blotting and IFA were used to assess protein level, visualize protein 
localization, and confirm HSV-1 infection.  Although our results are currently 
inconclusive, parts of our data offer clues as to how HSV-1 affects AQP4 protein.  We 
have demonstrated, as seen in Figure 5, that AQP4 protein was reduced by HSV-1 
infection.  Based on the preliminary results, higher MOI and longer infection time could 
result in further reduction of AQP4.  These results suggest that HSV-1 is potentially able 
to reduce AQP4 and consequently modulate the glymphatic system.  If the AQP4 protein 
were significantly reduced, the bulk ISF and CSF flow would slow down and the rate of 
clearance would decrease considerably.  This slower removal could lead to the harmful β-
amyloid plaque build-up, which can in turn trigger neurodegenerative disease.  
Understanding how viral infection can alter the waste clearance pathway in the brain may 
facilitate the development of treatment strategies targeting these pathways.    
Future research on HSV-1 effect on AQP4 is warranted as our observations need 
to be confirmed with repeated experiments.  The effect of HSV-1 on AQP4 transcript 
needs to be studied to determine if AQP4 protein reduction is due to a transcript level 
change.  If not, one of the experiments to test for the protein level degradation is to use 
proteasome inhibitor MG132 (Yang et al., 2016).  This test would assess if the ubiquitin-
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proteasome degradation pathway is used to degrade AQP4 in HSV-1 infected cells.  If 
this follow-up test has positive results, it will indicate that AQP4 reduction is due to 
degradation by the ubiquitin-proteasome pathway.  Upon identifying the molecular 
mechanisms in vitro, further research could include in vivo tests to assess the effects of 
HSV-1 infection on the glymphatic system and its function as a whole.  An animal model 
would also provide a more realistic and therefore improve model in assessing the 
prevalence of HSV-1 infection in astrocytes and whether its effect on AQP4 would be 
severe.  Future extensions from this project could have major impacts on understanding 
the molecular process by which the glymphatic system functions including how the 
AQP4 change by HSV-1 infection induces its malfunction and consequently the 
development of neurodegenerative diseases.    
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